- Despite Previous Data, Paxlovid May Be Useful for Long Covid After All
- Some GLP-1s Achieve More Weight Loss Than Others: Study
- More Evidence Bolsters the Oral Herpes and Alzheimer’s Link
- Health Advocates Are Unhappy with FDA Guidance on Lead Levels in Baby Food
- FDA Calls for Better Accuracy of Pulse Oximeters in People of Color
- Fluoride May Be Linked to Decreased IQ, Says “Limited Data,” Hard-to-Interpret Study
- First U.S. Death From Bird Flu Reported in Louisiana
- Blood Test May Help Predict How Long Immunity Lasts
- DoxyPEP Lowers Rate of Sexually Transmitted Infections (STIs), Data Suggests
- Multilingual Children with Autism Show Improved Cognitive Function
First Wire-Free Pacemaker Approved
The first pacemaker to treat irregular heartbeat without the need for wires between the device and the heart has been approved by the U.S. Food and Drug Administration.
The Micra Transcatheter Pacing System is implanted in the heart’s right ventricle, the FDA said in a news release. In traditional pacemakers, wired leads may malfunction and require the device to be replaced.
The device was evaluated in clinical studies involving 719 people. About 98 percent of people given the device had “adequate heart pacing” six months after surgical implantation, the FDA said. Complications, which affected fewer than 7 percent of trial participants, included extended hospitalization, blood clots in the legs or lungs, heart injury, device dislocation and heart attack.
The device shouldn’t be implanted in severely obese people, or in people who may be intolerant to its components or to the blood-thinning drug heparin, the agency said.
The device is manufactured by Medtronic, based in Mounds View, Minn.
More information
The FDA has more about this approval.
Source: HealthDay
Copyright © 2025 HealthDay. All rights reserved.